Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 157
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we use our immune cells to fight lung disease?

Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

Can we utilize natural bat colony behavior as a vaccination strategy?

Bats are one of the most prolific and ecologically important groups of mammals on the planet, but they are...

kwiKBio: Empowering citizen scientist superheroes to cure disease

My mother has Alzheimer's. My father suffered a stroke. A close friend's daughter, cystic fibrosis. My...

Backer Badge Funded